drug revert epigenetic silent dna methyltransferase inhibitor anti azacytidin aza profound effect transcript tumor cell survive approve drug myelodysplast syndrome act myeloid leukemia investing differ solid align tumor treatment genre self doublestrand rna dna transcript hypomethyl repeat element accueil dnmtitreat cell lead type in product ifnstimul gene express report death response occur oligoadenyl synthetase oasrnas l pathway was ifninduc enzyme synths nase active deficit oa highly resist wildly treat smallmolecul jun nhtermin kind jk also antigen depend consist role jk lineup apoptosis contrast rate azainduc increase transfer deficit radar edit detail pde aka degrade ionic radial induce ifndepend signal final correct density nci set line suggest level biomass predict studi may events lead pharmacology strategy regal antitumor active toxic relay 